Source:http://linkedlifedata.com/resource/pubmed/id/12436486
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-11-18
|
pubmed:abstractText |
This study examined the association between HHV-6 infection and multiple sclerosis (MS) and the relationship between HHV-6 reactivation and disease activity. The frequency of HHV-6 genomic sequences in peripheral blood mononuclear cells (PBMCs), the incidence of plasma viremia (nPCR), the transcription of viral mRNA in PBMCs (RT-PCR), the presence of antiviral IgM and IgG class antibodies in the plasma (IFA) of 16 relapsing/remitting and secondary progressive MS patients were studied in comparison with clinical manifestations of the disease, magnetic resonance imaging (MRI) of brain, and serum interleukin (IL)-12 concentrations (ELISA). The prevalence of HHV-6 infection was significantly higher in patients with MS (16/26) than in patients with other neurological diseases (6/21) and in blood donors (43/150). HHV-6 reactivation was found during periods of disease activity with Gadolinium-enhancing lesions on MRI in both relapsing/remitting and secondary progressive MS (10/13; 76.9%). In patients with active MS disease, serum concentrations of IL-12 were significantly higher in those patients with active HHV-6 infection than in patients with latent infection. The data confirm an association between HHV-6 infection and MS and show a correlation between HHV-6 reactivation and disease activity in relapsing/remitting and secondary progressive MS. The risk of an exacerbation of MS was significantly higher (P < 0.005) in patients with active HHV-6 infection than in patients with latent infection. A clear correlation between HHV-6 reactivation and serum IL-12 concentrations during disease activity has been demonstrated. The results suggest that HHV-6 reactivation is implicated in exacerbation of MS, possibly through modulation of IL-12 synthesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0146-6615
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
111-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12436486-Cells, Cultured,
pubmed-meshheading:12436486-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12436486-Herpesviridae Infections,
pubmed-meshheading:12436486-Herpesvirus 6, Human,
pubmed-meshheading:12436486-Humans,
pubmed-meshheading:12436486-Immunoglobulin G,
pubmed-meshheading:12436486-Immunoglobulin M,
pubmed-meshheading:12436486-Leukocytes, Mononuclear,
pubmed-meshheading:12436486-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:12436486-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12436486-Virus Activation
|
pubmed:year |
2003
|
pubmed:articleTitle |
Correlation between HHV-6 reactivation and multiple sclerosis disease activity.
|
pubmed:affiliation |
August Kirchenstein Institute of Microbiology and Virology, University of Latvia, Riga, Latvia. modra@latnet.lv
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|